Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

U.S. Customs seized $83M worth of counterfeit medical devices, drugs in 2012

January 30, 2013 2:37 pm | by Mass Device | News | Comments

Counterfeit medical products accounted for 9% of all seizures by U.S. Customs and Border Protection last year, nearly 1/3 less than confiscated in 2011. U.S. Customs & Border Protection seized more than 2,350 parcels containing counterfeit medical devices and pharmaceutical products last year valued at $83 million, according a new report from the U.S. Dept. of Homeland Security. Legal News, News Well, Patient Safetyread more

SEMDA Announces Record Number of Presenting Companies for 2013 Conference

January 30, 2013 1:42 pm | by The Associated Press | News | Comments

Selecting from a record number of applicants for the 2013 Conference, the Southeastern Medical Device Association (SEMDA) has chosen 20 outstanding companies to present to investors. The companies include Series B, early revenue and emerging companies, all with compelling technologies and...

Configurable CAD Models For Brushless DC Motors

January 30, 2013 11:25 am | Pittman | Product Releases | Comments

PITTMAN Motors, a unit of AMETEK Precision Motion Control, has introduced configurable 3D CAD model downloads for its entire offering of brushless DC motors. The 3D model system is an online system...

Advertisement

Reliable Three-Phase Transformers

January 30, 2013 10:55 am | Product Releases | Comments

With their advanced performance, rugged construction and superior reliability, the modular IPI Three-Phase Transformer Series from Innovative Power, Inc., delivers superior power management in a wide range of instruments...

NeuroMetrix Launches Website for SENSUS™ Pain Management System

January 30, 2013 10:20 am | by The Associated Press | News | Comments

WALTHAM, Mass.--(BUSINESS WIRE)--Jan 30, 2013--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced that is has launched a website ( www.neurometrix.com/sensus ) for the...

Thermal Gel Sheets

January 30, 2013 10:16 am | Fujipoly America Corp. | Product Releases | Comments

Fujipoly announces the availability of Sarcon® 50GR-Ae, an extremely soft 0.5-mm thick thermal interface material. The gel-like sheet compound is designed to efficiently transfer heat from its source to a nearby heat sink.

Adhesive Dispensers for Dual Barrel Cartridges

January 30, 2013 10:13 am | by MDT Staff | Product Releases | Comments

A full line of pneumatic bench top adhesive dispensers for standard dual barrel cartridges that eliminates operator fatigue and increases productivity is available from Ashby Cross Company.

St. Jude Medical Announces First Patient Enrollment in EnligHTN II Renal Denervation Study

January 30, 2013 9:00 am | by The Associated Press | News | Comments

ST. PAUL, Minn.--(BUSINESS WIRE)--Jan 30, 2013--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced enrollment of the first patient in the EnligHTN II trial. This post-market clinical study will further evaluate the safety and efficacy of the EnligHTN ™ Renal...

Advertisement

SpectraScience and PENTAX Showcase WaveSTAT4 Optical Biopsy System at Arab Health 2013

January 30, 2013 9:00 am | by The Associated Press | News | Comments

SpectraScience, Inc. (OTCQB: SCIE), a San Diego based medical device company, today announced that in continuation of its distribution and sales efforts in Europe and the Middle East it is demonstrating its WavSTAT4 Optical Biopsy System at the 38th Annual Arab Health 2013 Exhibition and...

Medtronic Completes Strategic Investment in LifeTech Scientific Corporation

January 30, 2013 8:36 am | by The Associated Press | News | Comments

Strategic Alliance to Leverage Best of Both Companies to Reach Cardiovascular Patients in China and Other Emerging Markets MINNEAPOLIS and Shenzhen - January 30, 2013 - Medtronic, Inc. (NYSE:MDT)...

Medtronic Introduces the First and Only Neurostimulation Systems with CE Mark Approval for Full-Body MRI Scans

January 30, 2013 8:06 am | by The Associated Press | News | Comments

TOLOCHENAZ AND MINNEAPOLIS - January 30, 2013 - Medtronic, Inc. (NYSE: MDT) today introduced in Europe the first and only implantable neurostimulation systems indicated for use in the treatment of chronic back and/or leg pain that are designed for full-body Magnetic Resonance...

Organovo and OHSU Knight Cancer Institute Announce Collaboration in Cancer Research

January 30, 2013 8:05 am | by The Associated Press | News | Comments

Organovo Holdings, Inc. (OTCQX: ONVO) ("Organovo"), a creator and manufacturer of functional, three-dimensional human tissues for medical research and therapeutic applications, and the Knight Cancer Institute at Oregon Health & Science University (OHSU), a national leader in translational...

21st Century Oncology Introduces Comprehensive New Website

January 30, 2013 8:00 am | by The Associated Press | News | Comments

FORT MYERS, Fla.--(BUSINESS WIRE)--Jan 30, 2013--Radiation Therapy Services, Inc., also known as 21 st Century Oncology – the nation’s premier cancer treatment network and largest radiation therapy provider – is pleased to announce the launch of their new website. 21stCenturyOncology.com is now...

MyoKardia Appoints Industry Veteran Jonathan Fox, M.D., Ph.D., as Chief Medical Officer

January 30, 2013 8:00 am | by The Associated Press | News | Comments

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jan 30, 2013--MyoKardia, Inc., a company focused on developing innovative therapeutics to treat genetic cardiovascular disease, today announced the appointment of Jonathan C. Fox, M.D., Ph.D., as Chief Medical Officer. In his role, Dr. Fox will be...

Svelte Medical Systems Announces Treatment of First Patient in the DIRECT II Drug-Eluting Stent Study

January 30, 2013 7:00 am | by The Associated Press | News | Comments

NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--Jan 30, 2013--Svelte® Medical Systems today announced treatment of the first patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug Carrier Technology) study at Middelheim Hospital in Antwerp, Belgium. DIRECT II is a...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading